Opening the Door for Novel Therapies in Triple-Negative Breast Cancer

Jennifer Logan, MD, MPH
Published: Tuesday, Mar 31, 2020
Debu Tripathy, MD, Professor and Chairman Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Debu Tripathy, MD

A wave of change has taken hold of the treatment landscape for triple-negative breast cancer (TNBC). Recent successes demonstrated in clinical trial data have led to the approval of new immunotherapy and targeted agents, thanks in part to the molecular classification of TNBC.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication